The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010


Poster Presenter

New Dietary Supplement And Their Eventual Using For Weight

Hlubik P., Stritecka H., Hlubik J., Pavlik V., Fajfrova J, Voseckova A, Husarova M
Czech Republic

The prevalence and incidence of obesity increase during the last 10 year in whole world. Obesity is a risk factor leading to many serious civilization diseases such as Insulin resistance, Diabetes mellitus II. Type, dyslipidaemia -small dense oxide LDL.

The aim of work was the investigation of the change of selected anthropometrical and biochemical parameters (BMI, waist circumference, % of body fat, serum concentrations of total cholesterol, HDL and LDL, TAG ) during 3 month controlled, non pharmacology regime of weight reduction using dietary supplement Sternax (50 mg dry extract from Leuzea, 100 mg caffeine) 1 dose per day with simultaneous restrict of dietary energy.

The results of the study proved that there is a positive effect of a targeted reduction diet on obese persons. Following the three-month therapy, weight loss, decrease of body fat, lower waist circumference, improved lipid profile and decreased of systolic as well as diastolic blood pressure were demonstrated. On the other hand 50% monitored people noted increase of appetite especially of sweet.
Using dietary supplements is one of way how to reduce body weight. Supported by MO FVZ 0000502















[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy